Sunday, September 19, 2021 4:53:02 PM
Recent LUMO News
- Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024 • GlobeNewswire Inc. • 07/23/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:08:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:07:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:07:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:07:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:07:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:06:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:09:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 09:02:28 PM
- Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024 • GlobeNewswire Inc. • 06/04/2024 01:00:00 PM
- Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024 • GlobeNewswire Inc. • 05/20/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 01:57:40 PM
- Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/14/2024 08:15:00 PM
- Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024 • GlobeNewswire Inc. • 05/09/2024 06:51:02 PM
- Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings • GlobeNewswire Inc. • 04/18/2024 08:05:00 PM
- Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042 • GlobeNewswire Inc. • 03/20/2024 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:48:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:44:25 PM
- Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update • GlobeNewswire Inc. • 03/07/2024 09:01:00 PM
- Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024 • GlobeNewswire Inc. • 02/26/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 10:22:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2024 09:02:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 10:55:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 10:54:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 10:53:28 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM